Back

Suspected de novo heart failure in outpatient care: high mortality and morbidity rates (REVOLUTION HF)

11 May 2024 (09:18 - 09:26)
Organised by: Logo
Congress Presentation Part of: Late breaking clinical trials I Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Lisa Anderson

St George's University Hospital NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)

9 More presentations in this session

Presentation thumbnail
Timing of Cardio-Kidney Protection with SGLT2 Inhibitors: Insights from Four Large-scale Placebo-Controlled Outcome Trials
Doctor M. Vaduganathan (Boston, US)
Slides Video
Presentation thumbnail
Discussant review - CANVAS Program, CREDENCE, DAPA-HF, and DELIVER
Professor M. Packer (Dallas, US)
Slides Video
Presentation thumbnail
Intravenous iron therapy with ferric carboxymaltose results in a rapid and sustained rise in myocardial iron content through a non-canonical pathway: a translational study
Professor S. Lakhal-Littleton (Oxford, GB)
Slides Video
Presentation thumbnail
Discussant review - IV iron and the heart
Professor E. Jankowska (Wroclaw, PL)
Slides Video
Presentation thumbnail
Impact of a remote monitoring program on all-cause mortality of patients with heart failure: National, real-world evidence of the TELESAT study
Professor N. Girerd (Nancy, FR)
Slides Video

Access the full session

Session thumbnail
Late breaking clinical trials I
Video

The Event

Event poster

Heart Failure 2024

11 May 2024 09:18 CET
You may be interested in
thumbnail
Congress Session
Late breaking clinical trials I

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources